Pierre Sonveaux, PhD, is the Director of the team of Tumor Metabolism (TUMETABO) at the Pole of Pharmacology & Therapeutics of the IREC Institute at the Université catholique de Louvain (UCL) Medical School in Brussels, Belgium. He is Professor of Pharmacology and Senior Research Associate of the Belgian National Fund for Scientific Research (F.R.S.-FNRS). Prof. Sonveaux is President of the International Society of Tumor Metabolism (ISCaM) and a member of the Editorial Boards of Cancer Research, Frontiers in Pharmacology and Cell Stress. Research by his team aim to characterize cancer metabolism in tumors as an organ in order to identify and validate new anticancer targets. Based on collaborative work, key achievements include the identification of a metabolic symbiosis in cancer, and of mitochondrial superoxide as an amenable target for the prevention of cancer metastasis. Prof. Sonveaux received several awards, including the ESTRO-VARIAN-Juliana Denekamp Award 2007, the FECS-EJC Award 2007, the Galien Prize in Pharmacology 2010, the EACR Highly Commended Award in 2010 and the AstraZeneca Prize in Oncology 2016. He is Officer of the Walloon Merit Order, Belgium.